Health Catalyst, Inc. (HCAT)

Health Catalyst Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	60.59	50.81	249.65	106.28	116.31	193.23
Short-Term Investments	42.85	44.92	142.36	211.45	247.18	251.75
Cash & Short-Term Investments	103.44	95.73	392	317.73	363.49	444.98
Cash Growth	6.27%	-75.58%	23.38%	-12.59%	-18.31%	64.28%
Accounts Receivable	41.9	59.13	57.18	60.29	47.97	48.8
Other Receivables	0.2	0.3	0.6	0.9	0.6	0.8
Receivables	42.1	59.43	57.78	61.19	48.57	49.6
Prepaid Expenses	9.83	12.35	13.77	12.28	14.24	12.41
Other Current Assets	93.02	1.8	2.1	2.2	1.5	1.4
Total Current Assets	248.39	169.31	465.65	393.4	427.8	508.39
Property, Plant & Equipment	39.41	40.48	41.45	39.64	42.59	44.45
Goodwill	11.1	209.07	259.76	190.65	185.98	169.97
Other Intangible Assets	56.12	77.68	86.05	73.38	92.19	104.79
Long-Term Deferred Charges	1.8	2.4	2.9	3.3	2.6	3
Other Long-Term Assets	1.78	3.71	3.12	1.44	1.13	1.5
Total Assets	358.6	502.64	858.93	701.81	752.29	832.1

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	8.34	9.36	11.43	6.64	4.42	4.69
Accrued Expenses	22.39	17.99	26.34	20.93	17.85	23.73
Current Portion of Long-Term Debt	1.63	1.63	231.18	-	-	-
Current Portion of Leases	3.7	3.78	3.61	3.36	3.43	3.43
Current Unearned Revenue	42.53	56.11	53.28	55.75	54.96	56.63
Other Current Liabilities	13.34	0.7	-	2.36	1.84	4.58
Total Current Liabilities	91.93	89.57	325.85	89.03	82.51	93.05
Long-Term Debt	151.85	151.62	151.18	228.03	226.52	180.94
Long-Term Leases	12.8	14.21	16.29	17.68	18.02	20.24
Long-Term Unearned Revenue	0.43	0.41	0.25	0.08	0.11	0.93
Long-Term Deferred Tax Liabilities	-	0.23	0.16	0.07	0.07	-
Other Long-Term Liabilities	0.78	0.82	-0	0	0.06	14.83
Total Liabilities	257.78	256.86	493.72	334.9	327.28	310

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	1,616	1,609	1,553	1,484	1,425	1,401
Retained Earnings	-1,516	-1,365	-1,187	-1,117	-999.02	-878.86
Comprehensive Income & Other	1.03	1.59	-0.84	0.03	-0.65	-0.07
Total Common Equity	100.83	245.78	365.21	366.92	425.01	522.1
Shareholders' Equity	100.83	245.78	365.21	366.92	425.01	522.1
Total Liabilities & Equity	358.6	502.64	858.93	701.81	752.29	832.1

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	169.98	171.24	402.27	249.07	247.97	204.61
Net Cash (Debt)	-66.54	-75.51	-10.27	68.66	115.52	240.37
Net Cash Growth	-	-	-	-40.56%	-51.94%	218.01%
Net Cash Per Share	-0.92	-1.08	-0.17	1.22	2.14	5.06
Filing Date Shares Outstanding	75.26	73.59	70.21	58.56	55.81	53.35
Total Common Shares Outstanding	74.6	72.03	64.04	58.3	55.26	52.62
Working Capital	156.47	79.73	139.8	304.36	345.29	415.34
Book Value Per Share	1.35	3.41	5.70	6.29	7.69	9.92
Tangible Book Value	33.61	-40.97	19.4	102.88	146.84	247.34
Tangible Book Value Per Share	0.45	-0.57	0.30	1.76	2.66	4.70
Machinery	12.16	13.82	14.07	13.37	13.75	12.95
Leasehold Improvements	6.15	6.31	8.46	8.81	9.97	10.83

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: May 11, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 13, 2026

Data Sources Report a data error